We are live on ! Find out more
PAHC icon

Phibro Animal Health

133 hedge funds and large institutions have $311M invested in Phibro Animal Health in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 53 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more call options, than puts

Call options by funds: $141K | Put options by funds: $60K

19% more capital invested

Capital invested by funds: $261M → $311M (+$49.9M)

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

1.53% more ownership

Funds ownership: 98.28%99.81% (+1.5%)

1% more funds holding

Funds holding: 132133 (+1)

15% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 53

Holders
133
Holders Change
+1
Holders Change %
+0.76%
% of All Funds
2.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
45
Reduced
53
Closed
14
Calls
$141K
Puts
$60K
Net Calls
+$81K
Net Calls Change
+$52K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$52.9M -$3.21M -210,220 -6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$34.7M -$1.52M -99,586 -4%
Pzena Investment Management
3
Pzena Investment Management
New York
$33.2M +$2.99M +195,964 +10%
BIP
4
Brandes Investment Partners
California
$19.6M +$9.79M +640,958 +100%
State Street
5
State Street
Massachusetts
$14.3M +$295K +19,332 +2%
HA
6
Heartland Advisors
Wisconsin
$11.2M +$250K +16,334 +2%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$9.3M +$1.36M +88,811 +17%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$8.88M -$2.31M -150,964 -21%
Renaissance Technologies
9
Renaissance Technologies
New York
$8.03M -$118K -7,700 -1%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$7.39M -$178K -11,661 -2%
SGCIA
11
Smith Graham & Co Investment Advisors
Texas
$7.27M -$22.4K -1,464 -0.3%
Morgan Stanley
12
Morgan Stanley
New York
$6.61M -$551K -36,082 -8%
N
13
Nuveen
North Carolina
$6.37M +$1.05M +68,881 +20%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$5.96M +$15.1K +989 +0.3%
Ameriprise
15
Ameriprise
Minnesota
$5.89M +$100K +6,566 +2%
Goldman Sachs
16
Goldman Sachs
New York
$5.72M -$90.3K -5,913 -2%
Hotchkis & Wiley Capital Management
17
Hotchkis & Wiley Capital Management
California
$5.5M +$13.8K +900 +0.3%
AQR Capital Management
18
AQR Capital Management
Connecticut
$4.61M +$458K +29,991 +11%
Charles Schwab
19
Charles Schwab
California
$4.54M +$41.1K +2,691 +0.9%
Invesco
20
Invesco
Georgia
$4.42M -$200K -13,064 -4%
Northern Trust
21
Northern Trust
Illinois
$3.55M +$63.3K +4,141 +2%
Wells Fargo
22
Wells Fargo
California
$3.13M +$135K +8,867 +5%
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$2.68M +$603K +39,441 +29%
DIA
24
Dean Investment Associates
Ohio
$2.65M +$2.64M +173,081 New
SEI Investments
25
SEI Investments
Pennsylvania
$2.64M -$48K -3,140 -2%

PAHC Hedge Fund Activity: Q1 2023 in Review

133 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2023, worth a combined $311M — up 19% from $261M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new PAHC positions and 14 closed out — a net gain of 2 holders — while 45 added to existing stakes and 53 trimmed.

The largest buyer was Brandes Investment Partners, adding an estimated $9.79M. The largest seller was BlackRock, cutting an estimated $3.21M.

  • 133 institutional investors held Phibro Animal Health (PAHC) as of Q1 2023, up from 132 in Q4 2022.
  • Funds reported $311M of Phibro Animal Health stock for Q1 2023, up 19% quarter-over-quarter.
  • 16 funds opened new Phibro Animal Health positions in Q1 2023 and 14 closed out, a net change of +2 holders.
  • The largest Phibro Animal Health buyer in Q1 2023 was Brandes Investment Partners, an estimated $9.79M added.
  • The largest Phibro Animal Health seller in Q1 2023 was BlackRock, an estimated $3.21M sold.

Based on aggregated 13F filings for Q1 2023.